Gadolinium-labeled affibody-XTEN recombinant vector for detection of HER2+ lesions of ovarian cancer lung metastasis using quantitative MRI
Author:
Publisher
Elsevier BV
Subject
Pharmaceutical Science
Reference37 articles.
1. Inconsistency of HER2 test raises questions;Tuma;J. Natl. Cancer Inst.,2007
2. Tumor-initiating cells of HER2-positive carcinoma cell lines express the highest oncoprotein levels and are sensitive to trastuzumab;Magnifico;Clin. Cancer Res.,2009
3. Imaging and differential diagnosis of ovarian cancer;Shetty;Semin. Ultrasound CT MR,2019
4. Prognostic utility of FDG PET/CT in advanced ovarian, fallopian and primary peritoneal high-grade serous cancer patients before and after neoadjuvant chemotherapy;Watanabe;Ann. Nucl. Med.,2020
5. Dual-labeled trastuzumab-based imaging agent for the detection of human epidermal growth factor receptor 2 overexpression in breast cancer;Sampath;J. Nucl. Med.,2007
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Recent advances of affibody molecules in biomedical applications;Bioorganic & Medicinal Chemistry;2024-11
2. Polypeptides as alternatives to PEGylation of therapeutic agents;Expert Opinion on Drug Delivery;2023-12-25
3. Replication stress and defective checkpoints make fallopian tube epithelial cells putative drivers of high-grade serous ovarian cancer;Cell Reports;2023-10
4. A high affinity and specificity anti-HER2 single-domain antibody (VHH) that targets trastuzumab’s epitope with versatile biochemical, biological, and medical applications;Immunologic Research;2023-08-26
5. Unstructured polypeptides as a versatile drug delivery technology;Acta Biomaterialia;2023-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3